This week, the American Association for Cancer Research (AACR) released its AACR Cancer Disparities Progress Report 2022. According to the report, while overall cancer incidence and mortality rates are declining across all groups, disparities across the cancer continuum remain a public health challenge. The report cites the need for more funding, increased representation of patients from different […]
Pingping Hou, PhD, of Rutgers Cancer Institute of New Jersey and Edwin Manuel, PhD, of the City of Hope, were announced at the American Association for Cancer Research (AACR) Annual Meeting 2022 as the latest recipients of the Lustgarten FoundationAACR Career Development Awards for Pancreatic Cancer Research in Honor of Ruth Bader Ginsburg and John […]
Tony Hunter is one of four co-principal investigators in the Salk Dedicated Program in Pancreatic Cancer, which is funded by the Lustgarten Foundation.
Researchers at The University of Texas MD Anderson Cancer Center have discovered that two distinct classes of cancer-associated fibroblasts (CAFs) accumulate in the pancreatic tumor microenvironment and play opposing roles to promote and restrain pancreatic cancer development.
Researchers have successfully increased survival rates in pancreatic cancer mouse models by blocking a key pathway in the immune system, which more than doubled survival.
UC San Diego study detects tell-tale proteins released into circulation by cancer cells
Florida-based Singh Biotechnology is developing a new treatment approach that can shut off the “master switch” that controls cancer growth. This could revolutionize how we treat deadly cancers like pancreatic.